Stephen Johnston
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in ⓘ
- Oncology 172
- HER2/EGFR in Cancer Research 102
- Cancer Treatment and Pharmacology 53
- Cancer-related Molecular Pathways 23
- Lung Cancer Research Studies 21
-
- Advanced Breast Cancer Therapies 107
- Co-authors
- Mitch Dowsett (54 shared papers)Lesley‐Ann Martin (20 shared papers)Ian E. Smith (21 shared papers)Simone Detre (14 shared papers)Alexandra Léary (9 shared papers)Lisa O’Rourke (10 shared papers)J. Maltzman (9 shared papers)Xavier Pivot (8 shared papers)
- Journals
- Journal of Clinical Oncology (43 papers)Cancer Research (23 papers)Annals of Oncology (17 papers)Breast Cancer Research and Treatment (16 papers)Clinical Cancer Research (11 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Stephen Johnston
227 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 6.3k
- Cancer Research 3.1k
- Pulmonary and Respiratory Medicine 4.3k
- Genetics 974
- Genetics 2.0k
Countries citing papers authored by Stephen Johnston
This map shows the geographic impact of Stephen Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Johnston more than expected).
Fields of papers citing papers by Stephen Johnston
This network shows the impact of papers produced by Stephen Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Johnston. The network helps show where Stephen Johnston may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Johnston, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 236 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer Hit paper breakdown → | 2009 | 766 |
| 2 | The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2 Hit paper breakdown → | 2019 | 590 |
| 3 | Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer Hit paper breakdown → | 2016 | 507 |
| 4 | Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Hit paper breakdown → | 2016 | 446 |
| 5 | MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer Hit paper breakdown → | 2019 | 407 |
| 6 | 2005 | 378 | |
| 7 | 2003 | 246 | |
| 8 | 2016 | 219 | |
| 9 | In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer. | 1995 | 211 |
| 10 | 2008 | 180 | |
| 11 | 2020 | 173 | |
| 12 | 2010 | 161 | |
| 13 | 2010 | 158 | |
| 14 | Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer. | 1997 | 156 |
| 15 | 2008 | 152 | |
| 16 | 2006 | 129 | |
| 17 | 2006 | 119 | |
| 18 | 1998 | 112 | |
| 19 | 2010 | 111 | |
| 20 | Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer. | 2003 | 111 |
About Stephen Johnston
Stephen Johnston is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Molecular Biology, having authored 236 papers that have together received 9.3k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (107 papers), HER2/EGFR in Cancer Research (102 papers), Estrogen and related hormone effects (55 papers), Cancer Treatment and Pharmacology (53 papers), Breast Cancer Treatment Studies (53 papers), Cancer-related Molecular Pathways (23 papers), Lung Cancer Research Studies (21 papers) and Chronic Lymphocytic Leukemia Research (18 papers). The work is most often cited by research in Oncology (6.3k citations), Cancer Research (3.1k citations), Pulmonary and Respiratory Medicine (4.3k citations), Genetics (974 citations) and Genetics (2.0k citations). Stephen Johnston has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Mitch Dowsett, Lesley‐Ann Martin, Ian E. Smith, Simone Detre, Alexandra Léary, Lisa O’Rourke, J. Maltzman, Xavier Pivot, Allison Florance and Masakazu Toi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Cancer Research and Treatment and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.